What type of study is this?

This is a In Vitro Study study.

What question did this study set out to answer?

This research aims to characterize the functional impact of a novel germline JAK2 R989fs mutation.

December 8, 2025BloodOpen Access

Functional characterization of a novel germline JAK2 R989fs mutation

View Full Paper

Ask AI

Bookmark

Authors

JSJihyun Song LLLucie Lanikova

Discussion

Member takes

Overview

Functional analysis reveals JAK2 R989fs mutation enhances thrombocytosis and myelopoiesis indicators in a young woman, suggesting clinical significance.

Key Points

This research aims to characterize the functional impact of a novel germline JAK2 R989fs mutation.
Identified the mutation using next generation sequencing.
Examined clinical phenotype in a 24-year-old patient with thrombocytosis and low-normal erythropoietin levels.
Analyzed protein expression through Western blot and performed structural modeling with AlphaFold3.
JAK2 R989fs mutation results in a truncated kinase potentially leading to increased erythroid progenitor proliferation.
Patient exhibited thrombocytosis and abnormal hematological profiles, indicating active myelopoiesis.
Treatment with ropeginterferon alpha led to hematologic remission, normalizing p-STAT5 levels.

Cite This Study

Song et al. (2025) studied this question.

synapsesocial.com/papers/69362f7f4fa91c937236e5a7 https://doi.org/10.1182/blood-2025-5541

View Full Paper

Ask AI

Bookmark

December 8, 2025BloodOpen Access

Functional characterization of a novel germline JAK2 R989fs mutation

View Full Paper

Ask AI

Bookmark

Authors

JSJihyun Song LLLucie Lanikova

Discussion

Member takes

Overview

Functional analysis reveals JAK2 R989fs mutation enhances thrombocytosis and myelopoiesis indicators in a young woman, suggesting clinical significance.

Key Points

This research aims to characterize the functional impact of a novel germline JAK2 R989fs mutation.
Identified the mutation using next generation sequencing.
Examined clinical phenotype in a 24-year-old patient with thrombocytosis and low-normal erythropoietin levels.
Analyzed protein expression through Western blot and performed structural modeling with AlphaFold3.
JAK2 R989fs mutation results in a truncated kinase potentially leading to increased erythroid progenitor proliferation.
Patient exhibited thrombocytosis and abnormal hematological profiles, indicating active myelopoiesis.
Treatment with ropeginterferon alpha led to hematologic remission, normalizing p-STAT5 levels.

Cite This Study

Song et al. (2025) studied this question.

synapsesocial.com/papers/69362f7f4fa91c937236e5a7 https://doi.org/10.1182/blood-2025-5541

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark